Tissue specific expression of the retinoic acid receptor-beta 2: regulation by short open reading frames in the 5'-noncoding region by unknown
Tissue Specific Expression of the Retinoic Acid Receptor-/ 2: Regulation by 
Short Open Reading Frames in the 5"Noncoding Region 
Andreas Zimmer, Anne M. Zimmer, and Kay Reynolds 
Unit on Developmental Biology, Laboratory of Cell Biology, National Institute of Mental Health, Bethesda, Maryland 20892 
Abstract.  The 40-S subunit of eukaryotic ribosomes 
binds to the capped 5"end of mRNA and scans for the 
first AUG in a  favorable sequence context to initiate 
translation.  Most eukaryotic mRNAs therefore have a 
short 5'-untranslated  region (5"UTR) and no AUGs 
upstream of the translational  start site; features that 
seem to assure efficient translation.  However, ,o5-10% 
of all eukaryotic mRNAs, particularly those encoding 
for regulatory proteins,  have complex leader sequences 
that seem to compromise translational  initiation.  The 
retinoic-acid-receptor-/32  (RARB2) mRNA is such a 
transcript with a long (461  nucleotides) 5'-UTR that 
contains five, partially overlapping,  upstream open 
reading frames (uORFs) that precede the major ORE 
We have begun to investigate the function of this com- 
plex 5'-UTR in transgenic  mice, by introducing muta- 
tions in the start/stop codons of the uORFs in 
RAP-~2-1acZ  reporter constructs.  When we compared 
the expression patterns of mutant and wild-type con- 
structs we found that these mutations affected expres- 
sion of the downstream RAR~2-ORF, resulting in an 
altered regulation of RAP-~2-1acZ  expression in heart 
and brain.  Other tissues were unaffected. RNA analy- 
sis of adult tissues demonstrated that the uORFs act at 
the level of translation;  adult brains and hearts of 
transgenic mice carrying a construct with either the 
wild-type or a mutant UTR, had the same levels of 
mRNA, but only the mutant produced protein.  Our 
study outlines an unexpected role for uORFs: control 
of tissue-specific and developmentally regulated gene 
expression. 
I 
T is becoming increasingly  clear that the 5' and Y un- 
translated  regions (UTRs)  1  of many eukaryotic mRNAs 
play an important role in the regulation  of gene expres- 
sion by modulating  mRNA stability and  translational  ef- 
ficiency. In fact, the expression of many genes is primarily 
regulated  at  the posttranscriptional  level  (for review  see 
Jackson,  1993). 
The initiation of protein synthesis is often the rate limiting 
step and determines how much protein is synthesized  from 
one mRNA. According  to the scanning  model for transla- 
tional initiation,  the 40 S preinitiation  complex binds to the 
5'-cap site of the mRNA, and then migrates until it encoun- 
ters the first AUG in a favorable context to initiate  transla- 
tion.  However, in many eukaryotic genes, the first AUG is 
not the translational  start  site of the major open reading 
frame. In particular mRNAs that encode for proteins with a 
proposed function in cell growth and differentiation,  often 
have one or more AUGs or small  upstream open reading 
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frames (uORFs) that precede the major ORF (Kozak, 1991). 
These  AUGs  or  uORFs  usually  inhibit  translation  from 
downstream,  although  some  cases  have  been  described 
where uORFs stimulated  translation  of the major ORE 
The retinoic acid receptor-/~ (RAR/~) gene is one of those 
genes. It encodes a ligand-activated  transcription  factor and 
belongs to the superfamily  of nuclear hormone receptors 
(Evans, 1988). Retinoic acid (RA) plays a critical role during 
embryonic development,  homeostasis, and cell differentia- 
tion (for review see Eichele,  1993). Retinoic acid receptors 
act as molecular switches to transform  the RA signal into a 
transcriptional  response. 
The RARB gene encodes at least four different transcripts 
which are derived by differential  splicing and promoter us- 
age (Zelent et al., 1991; van der Leede et al., 1992; Nagpal 
et al.,  1992). These transcripts  contain common DNA and 
hormone-binding  domains,  but differ in the 5'-UTR and the 
NH2-terminal part of the receptor.  The RARB2 isoform has 
an unusually  long 5'-UTR (461 nucleotides)  that can form 
stable secondary structures and contains five small uORFs 
preceding the major ORF (de The et al.,  1987; Reynolds 
et  al,,  1991; Zelent et al.,  1991). Interestingly,  uORF2, 
uORF4, and uORF5 have a staggered organization  of over- 
lapping start and stop codons. Similarly overlapping uORFs 
can be found in other regulatory genes, like homeobox genes. 
It has been suggested that such an arrangement  might be par- 
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Gruss,  1988). 
We (Reynolds et al.,  1991; Zimmer and Zimmer, 1992) 
and others (Mendelsohn et al., 1991; Shen et al., 1992) have 
used RAR/32-1acZ reporter constructs in transgenic mice, to 
study the regulation of the RARB2 gene in normal embryos 
and after RA treatment. Our constructs were made by fusing 
the lacZ coding region to the NH2-terminus of the RARB2 
gene, leaving the 5' UTR intact. The expression pattern of 
the reporter gene constructs was tightly regulated during em- 
bryogenesis and closely followed that of the endogenous 
gene in most tissues. This was surprising, because it indi- 
cated that the 5'-UTR  did not inhibit translation, as one 
might have expected. However, close examination of  the pub- 
lished reports revealed some striking differences. For exam- 
ple, Mendelsohn et al.  (1991) and Shen et al.  (1992) both 
noted lacZ expression in the heart wall, which we never ob- 
served in our transgenics. Mendelsohn et al. (1991) and Shen 
et al. (1992) used constructs with a truncated 5'-UTR, thus 
indicating that this region might have indeed an important 
regulatory function that is not evident in all tissues. 
To address the role of the uORFs, we generated RARB2- 
lacZ reporter constructs with mutations in all upstream AUGs 
or with mutations in overlapping start and stop codons. The 
expression patterns in transgenic mice of the mutant con- 
structs were compared with a construct carrying the wild- 
type 5'-UTR (Reynolds et al.,  1991; Zimmer and Zimmer, 
1992).  We found that expression of the mutant constructs 
was differently regulated in heart and brain, suggesting that 
the uORFs play an important role in regulating tissue specific 
expression of the RARB2 mRNA. 
Materials and Methods 
Constructs 
Mutations in the RARff2-UTR were introduced using an oligenucleotide 
directed mntagenesis system (Amersham Corp., Arlington Heights, IL) ac- 
cording to the manufacturer's recommendations. The template for muta- 
genesis was a PstI fragment from the wild-type reporter construct RLZ79 
(Reynolds et al., 1991) inserted into M13mp18. The following oligonucleo- 
tides  were  used  for  site  directed  mutagenesis:  M24-CCCGA  ATCTA 
GAATT  ATGAC;  M45-ACGAA  CTCCA  AC_AAA CTCTC.  M0: 
uORF1-GTCCT  C~  ACCCA  GTCTT;  uORF2-TCATT  TACCA 
ATTTC CAGC~; uORF3-CC.AAA TGATC AATTA CCATT;  uORF4- 
CCCGA ACAA  GAATT  ATGAC;  uORF5-ACGAA  CTCCT  "ICAAA 
CTCTC. Mutations were verified by di-deoxy sequencing and the mutated 
PstI fragment was reinserted into RLZ79 aRer partial PstI digestion. 
Generation and Analysis of Transgenic Mice 
Transgenic mice were established and embryos were analyzed for B-gal ex- 
pression as previously described (Reynolds et al., 1991; Eisel et al., 1993). 
Briefly,  transgenic embryos were dissected from euthanized mothers and 
fixed for 30-120 rain at 40C in fixative (1% formaldehyde, 0.1% gluturalde- 
hyde, 0.02 % NP-40 in PBS). After fixation embryos were washed twice in 
PBS for 30 rain and incubated in staining solution (1 mg/ml 5-Bromo-4- 
Chloro-3-Indolyl-~-D-Galactapyranoside, 5 mM K3Fe(CN)6,  5 mM KaFe- 
(CN)6, 2 mM MgCI2) at 30"C overnight. For whole mount stainings of or- 
gans from adult animals all solutions were supplemented with NP-40 to a 
final concentration of 0.2%. For the preparation of cryosections, the em- 
bryos were soaked in a cryoprotectant solution (3% polyethyleneglycol, 20% 
sucrose in 0.1 M PBS pH 7.4) overnight. Subsequently, they were quickly 
frozen on dry ice and 20-#m thick sections were cut in a Reichert 2800 
Frigocut cryostat. All sections were counterstained with 0.1% neutral red. 
To analyze lacZ staining in deeper brain structures, adult brains were fresh 
frozen, sectioned, fixed for 15 rain at 4°C in fixative, washed twice in PBS, 
and incubated in staining solution at 300C  overnight. 
Pictures of histological sections and transgenic embryos were taken with 
a Zeiss Axiophot or Nikon stereomicroscope. Color images were scanned 
on Kodak Photo CD, processed with Adobe Photoshop, and printed on a 
Tektronics Phaser I/SDX. 
LacZ activity was measured in embryo or tissue extracts essentially as 
described (Ktnig et al., 1991). Briefly,  tissues were homogenized in PM2 
buffer (100  mM Na-phosphate,  2  mM  MgSO4,  0.1  mM  MnCl2,  0.5% 
(vol/vol) B-mercaptoethanol, pH 8.0). We used 500 t~l each embryo. Cell 
debris was pelleted by centrifugation in a microcentrifuge and 100 t~l of the 
supernatant was transferred either directly, or after dilution into a 96-well 
microtiter plate. The reaction was started by adding 25 ill of Chiorophenol 
red-B-D-galactopyranoside  solution (5 mg/ml in PM2 buffer ~  and measured 
in a microplate reader (OD at 570 nm). 
RNAse Protection  Assays 
RNA from adult organs was purified by homogenization in guanidiulum 
thiocyanate and centrifugation through a CsTFA gradient (Okayama et al., 
1987).  Quantitative RNA protection assays were performed essentially as 
described (Sambrook et al.,  1989).  10 #g of total RNA were hybridized 
with 1.5  x  l0  s cpm of probe in hybridization buffer (40 mM Pipes, pH 
6.4; 1 mM EDTA; 0.4 M NaC1; 80% formamide) at 50"C for 16 h. Subse- 
quently, 300 #1 RNAse digestion mixture (10 mM Tris, pH 7.4;  300 mM 
NaCI; 5 mM EDTA; 2 ttg/ml RNAse T1; 40 #g/ml RNAse A), was added 
and incubated at 37°C for 60 rain. The protected RNA was precipitated af- 
ter inactivation of RNAnses by proteinase K digestion and phenol/chloro- 
form extractions, dissolved in formamide loading buffer and separated on 
a 6% sequencing gel (Sequagel). Subsequently, the gels were dried and ana- 
lyzed using a Bio-Imaging Analyzer (Fuji BAS 2000).  Expression levels 
were quantitated using the "Radioaktive" function and also  independently 
after importing the raw data into a Macintosh Quadra 800 computer using 
the public domain NIH Image program (written by Wayne Rasband at the 
U.S. National Institutes of Health and available from the Internet by anony- 
mous tip from zippy.ulmh.nih.gov or on floppy disk from National Techni- 
cal Information Service, 5285 Port Royal P,d., Springfield, VA 22161, part 
number PB93-504868). 
Results 
The Y  UTR Is Highly Conserved between Mouse 
and Human 
The  short  upstream  open  reading  frames  in  the  RARe2 
5'-UTR  are  highly  conserved  between mouse  and human 
(Fig.  1; de The et al.,  1987;  Reynolds et al.,  1991;  Zelent 
et al., 1991),  which indicates that this region has an impor- 
tant  function.  Particularly  striking  is  the  overlapping  ar- 
rangement of uORF2, uORF4, and uOFR5. The stop codon 
of uORF2  overlaps with the uORF4  start  codon,  and the 
uORF4 stop codon overlaps with the AUG of uORF5 (Fig. 
1). The organization of these uORFs is almost identical in 
mouse and humans.  However, because of a frameshlft muta- 
tion in uORF3/uORFS, the amino acid sequence of the hu- 
man and mouse uORF5  peptides and the COOH-terminal 
half of the uORF3 peptides would be different. 
Mutations in Overlapping Start and Stop Codons 
Results in Altered Regulation of  LacZ Expression in 
Heart and Brain 
The reporter constructs used in this study were derived from 
the RAP.~2-1acZ  expression vector RLZ79 (Reynolds et al., 
1991).  This  construct  contained  about  1.25  kb  of RAR~ 
genomic  sequences,  including  the  RARe2  promoter,  the 
RAR/32 5'-UTR and the first 29 amino acids of the RAI~2- 
ORF,  to which the lacZ coding region was fused (Fig.  2). 
Consequently,  translation  of the lacZ gene was subject to 
potential control mechanisms located within the 5'-UTR. We 
analyzed the expression pattern  in transgenic founder em- 
bryos  and  transgenic  lines.  Transgenic  founder  embryos 
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Figure L  Comparison of the human and mouse RAR/T2 5'-UTRs. 
Shown are the sequences from the transcriptional start site (de The 
et al., 1990) to the RAR~2-AUG and the conceptual translation of 
all five uORFs. The amino acid sequence of uORF5 is indicated in 
bold letters, because uORF3 and uORF5 are in the same reading 
frame. 
were particularly  informative.  We  routinely  obtained  be- 
tween  10%  and  30%  transgenic  embryos from every lit- 
ter,  enabling us to examine several independently  derived 
founder animals within a single experiment. Transgenic lines 
were most useful for following the expression patterns dur- 
ing development. 
The first mutation tested, M24, had a two nucleotide ex- 
change in the uORb'2 stop codon and the uORF4 start codon 
(Fig. 2), thus extending uORb'2 (162 bp vs 63 bp) and delet- 
ing uORF4.  Four transgenic lines that expressed the trans- 
gene were derived with this construct.  The expression pat- 
tern was analyzed in embryos between day 9.5 and 12.5 post 
coitus (p.c.),  and in adults.  The expression patterns of the 
wild-type construct (RLZ79) and M24 were very similar in 
most tissues throughout development (Fig. 3). However, all 
M24 lines expressed lacZ at high levels in heart and three 
lines also expressed the transgene in the telencepha!on. Of 
two transgenic lines and 22  founder embryos derived with 
RLZ79, none expressed in the heart, and only one expressed 
at  detectable  levels in  the  brain.  LacZ  expression  in  the 
telencephalon of this embryo was much weaker than typi- 
Figure 2. Schematic representation of reporter plasmids employed 
in this study. The RARB2-1acZ  expression vector RLZ79 (Reynolds 
et al., 1991) contained ,x,1.25 kb of RARB genomic sequences, in- 
cluding the RARB2 promoter, the RAR4~2 5'-UTR and the first 29 
amino acids of the RARff2-ORF, to which the lacZ ceding region 
was fused.  Translation of the lacZ gene was subject to potential 
control  mechanisms  located  within  the  5'-UTR.  Open  reading 
frames in the 5'-UTR are indicated as lines. The exchange of two 
nucleotides in mutation M24 eliminates the uORb-2 stop codon and 
the uORF4 start codon. As a consequence, uORF2 terminates fur- 
ther downstream, and uORF5 is deleted. The single nucleotide ex- 
change in M45, mutates the uORF4 stop codon and the uORF5 start 
codon.  As uORF4  and the major ORF are in the same reading 
frame, the possibility exists that a larger fusion protein of uORF4 
and RAI<82-1acZ is made. In construct  M0, the AUGs of uORF1 
to uORF4 are mutated  by changing the adenine to a thymidine, 
while in uORF5 the thymidine was mutated to an adenine. 
cally observed in M24 embryos. Thus, the mutation in M24 
alters the regulation of expression of the RARB2-1acZ gene 
in heart and telencephalon. 
Two of the four lines also expressed at high levels in the 
peritoneum of day  12.5 embryos (Fig.  3 E).  However, we 
believe that this high level of expression can not be attributed 
to the mutation, because we also found lacZ expression in 
the peritoneum in •35  % of all RLZ79 embryos analyzed. 
The second construct,  M45,  had a  single nucleotide ex- 
change to mutate the uORF4 stop codon and the overlapping 
uORF5 start codon (Fig. 2). Because uORF4 and the major 
RARB2-1acZ ORF are in the same reading frame, this muta- 
tion could result in the production of a larger read-through 
fusion protein. With this construct we analyzed one trans- 
genic line and the litters from three independently derived 
transgenic  founder  mothers.  M45  embryos expressed the 
reporter gene at very high levels in the heart at all develop- 
Zimmer et al.  Tissue Specific Translational Regulation  1113 Figure 3. Mutations in the uORFs result in altered regulation of lacZ expression in the heart and brain of transgenic embryos. Whole mount 
staining of representative embryos at day 9.5 p.c. and 12.5 p.o. are shown in the upper panel (A, D, G, and K) and the middle panel (B, 
E, H, and L), respectively. Note laeZ expression in the telencephalon (arrows) of embryos derived with M24, M45, or M0. M45 embryos 
also expressed at high levels in the hearts of day 9.5 embryos (asterisk) while M24 expressed only weakly at this stage. Sagittal (C, F, 
and M) and transverse (I) sections show high levels of lacZ expression in the heart wall and also in papillary  muscles of day 12.5 p.c. 
M24 and M45 embryos. M0 expressed only in a few cells (M). 
mental stages and also at low levels in the brain. The M45 
expression pattern in other tissues was similar to the wild- 
type construct, although staining in the spinal cord of some 
M45 embryos was weaker (Fig. 3). These results suggest that 
the uORFs inhibit expression of the RAI~2-ORF in a tissue 
specific manner in heart and brain. 
fl-gal staining in the heart of M24 and M45 embryos was 
particularly strong in the heart wall and weaker in papillary 
muscle fibers (Fig.  3, F  and I). This distribution is not an 
artifact caused by incomplete penetration of the staining so- 
lution, as we found a similar pattern when the staining was 
performed with sections (data not shown). 
Both mutations exhibited a  distinct temporal expression 
pattern in heart and brain during development and also in 
adults (see Table I). For example, M24 embryos expressed 
lacZ in the heart only at moderate levels at day 9.5 p.c., when 
compared to M45 embryos. However, at day 12.5 p.c. and 
in adults,  lacZ staining in the heart was very similar with 
both constructs. In the brain, ~gal activity of M24 embryos 
and adult mice was very high throughout all developmental 
stages,  while M45 transgenics  showed much weaker lacZ 
staining. 
Deletion of  AU uORFs 
The mutations in M24 and M45 suggest that the altered regu- 
lation of lacZ expression is tissue specific. However, the pos- 
sibility exists that the presence of uORFs that were not af- 
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9.5  10.5  11.5  12.5 
Construct  TG lines  FO embs  H  B  H  B  H  B  H  B 
RLZ79  2  22  .......  * 
M0  1  10  +  + +  +  + +  nd  nd  +  + + 
M24  4t  0  +  ++  ++  +  ++  ++  +++  +++ 
M45  4  0  +++  +  +++  -  +++  +  +++  + 
Expression of 5'-UTR mutants in the heart (H) or the brain (B) of transgenic  mice. The number of transgenic  lines or transgenic  founder embryos that were ana- 
lyzed for each construct is indicated. -, no expression; +, weak expression; ++, strong expression; +++, very strong expression; nd, not done. 
* Of 22 founder embryos and two transgenic lines analyzed, only one expressed in the teleneephaion. 
t We examined  one transgenic  line throughout embr~nic development  and in adults, and the litters from three independently  derived transgenic  founder females 
on days 10.5 or 12.5 p.c., respectively. 
fected  by  these  mutations  may  prevent  translation of the 
major ORF in other tissues. It was therefore important to in- 
vestigate the expression  pattern of a  reporter  construct in 
which all uORFs were mutated. This was achieved by intro- 
ducing single nucleotide exchanges into all upstream AUGs. 
One transgenic line and 10 founder embryos were gener- 
ated with M0 and analyzed at different developmental stages. 
Representative day 9.5 and day  12.5 embryos are shown in 
Fig. 3, K  and L. The overall pattern of expression was very 
similar in RLZ79 and M0 embryos. However, M0 founders 
exhibited, as expected, lacZ activity in the heart and/or brain 
(Fig. 3, K-M), although expression in the heart was weaker 
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Figure  4.  Determination  of 
RAR~2-1acZ  RNA  and  pro- 
tein  levels  in  day  12.5  em- 
bryos. (A) Organization of the 
endogenous RAR/32  and  the 
transgene.  A  BsaAI-Bsu36I 
fragment of the transgene was 
used  to  synthesize  an  anti- 
sense RNA probe. The endog- 
enous RARB mRNAs protect 
a  187-nt fragment (BsaA1  to 
PstI). The transgene protects a 
423-nt  fragment  (BsaAI  to 
Bsu36I)  of the  RNA  probe. 
(B) Total RNA from various 
transgenic  embryos  was  hy- 
bridized  to  the  radiolabeled 
RNA probe and digested with 
RNAse  as  described  in Ma- 
terials and Methods. The pro- 
tected  fragments  were  sepa- 
rated  on  a  sequencing  gel 
(Sequagel) and analyzed using 
a  Bio-Imaging Analyzer. Ra- 
diolabeled  bluescriptSK+ 
DNA digested with HpalI was 
used as size-marker. Note that 
the  probe  overlaps  with  the 
AUG of uORF5. This AUG is 
mutated by a single nucleotide 
exchange in constructs M0. As 
a consequence RNA from M0 
and M45 embryos is partially 
cleaved  at  this  position  to 
yield a smaller fragment (indi- 
cated by asterisk). (C) Quan- 
titation of RARB2-1acZ RNA 
and  protein  levels.  Protein 
levels were determined enzy- 
matically in at least three em- 
bryos (see Materials and Meth- 
ods). RNA levels were estimated using a Bio-Imaging Analyzer (Fuji BAS 2000) and also independently after importing the raw data into 
a  Macintosh Quadra 800 computer using the public domain NIH Image program. 
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support our hypothesis that the translational regulation by 
the uORFs is tissue specific. 
It has previously been shown that uORFs can inhibit the 
translation of transfected constructs in cultured cells. To de- 
termine if the translation of the RLZ79 construct is also in- 
hibited in our transgenic lines, we wanted to compare the 
amount of protein made from the RLZ79 and the mutant 
constructs quantitatively. Therefore, day 12.5 embryos were 
isolated and the IacZ-mRNA and protein levels were deter- 
mined by RNAse protection and enzymatic assays, respec- 
tively. To facilitate the quantitation of RNA levels, we used 
a probe that simultaneously protected the endogenous RARB2 
mRNA  and the transgene (Fig.  4).  Thus,  the endogenous 
RARB expression level served as a reference. The compari- 
son of RNA and protein levels revealed similar protein/RNA 
ratios in RLZ79, M0, and M45 embryos. However, transla- 
tion of M24 was overall reduced, despite its strong expres- 
sion in heart and telencephalon. These data indicate that the 
uORFs in the wild-type construct do not inhibit translation 
of the major open reading frame in most tissues. 
mRNA, but Not Protein Expression, Is Similar 
in Mutant and gald-I)~e Mice 
To investigate whether the low lacZ levels in heart and brain 
of  the wild-type construct could be accounted for by reduced 
mRNA levels, we analyzed RARB2-1acZ RNA and protein 
in hearts and brains of adult RLZ79 and M24 transgenic 
mice. Preliminary experiments showed that the lacZ activity 
was readily detectable in organ extracts from M24 transgenic 
mice, while we failed to detect any lacZ activity above hack- 
ground in the hearts and brains of RLZ79 transgenic mice, 
when measured in enzymatic assays. Therefore, lacZ activity 
was estimated by staining of organs from several mice of 
similar age (3-6 mo), either as whole mounts or after sec- 
tioning. RNAs were analyzed in parallel. 
We found that RARB2-1acZ RNA levels were very similar 
in M24 and RLZ79 tissues (Fig. 5 B). However, 5-gal stain- 
ing patterns in both transgenic lines varied dramatically. In 
the brain,  RLZ79 expressed/3-gal activity only in a  very 
small number of neurons, while M24 stained for B-gal in a 
large number of cells in the cortex (Fig.  5 A), the medial 
habenular nucleus, the striatum, and the telencephalic epen- 
dyma (Fig. 6). The tS-gal activity in those few cells in the 
brains of RLZ79 mice that stained positive seemed to be 
similar to M24 mice./3-gal staining in the hearts was very 
strong in M24 transgenics, while RLZ79 transgenics were 
completely negative (Fig.  7).  These data indicate that the 
uORFs  inhibit  translation  of the  RARB2-1acZ  mRNA  in 
heart and brain. 
Figure 5.  LacZ expression in 
brain and heart of adult mice. 
(,4) Brain sections were cut af- 
ter B-gai staining and the tis- 
sue was  counterstained  with 
neutral  red  as  described  in 
Materials  and  Methods.  To 
visualize  the  /~-gal staining, 
sections  were  photographed 
with a red filter (left panel). 
The  right  panel  shows the 
same sections  photographed 
under  full  light  conditions. 
Non-transgenic  controls 
showed no/5-gal activity (top 
row). RLZ79 expressed only 
in very few cells in the cortex 
(middle  row),  while  M24 
(bottom row) expressed in a 
very large  number  of cells. 
(B) RNAse protection assays 
of hearts and brains. Analysis 
was performed as described in 
Fig.  3  and  Materials  and 
Methods.  The  wild-type 
RLZ79 mRNA is expressed in 
the  brain  at  slightly  higher 
levels than M24 although pro- 
tein  staining  is  detected  in 
fewer cells (see also Fig. 6). 
Expression  in  the  heart  is 
comparable  with  both  con- 
structs. Note however,  that we 
found  no  B-gai staining in 
RLZ79 hearts (Fig. 7). 
The Journal of Cell Biology,  Volume 127, 1994  1116 Figure 6. LacZ expression in the medial habenular nucleus, striatum, and ependyma. To compare lacZ expression in deeper brain structures 
between RLZ79 and M24, frozen sections  from adult brains were stained for fl-gal  activity.  (A and B) Sections  through the medial habenular 
nucleus of RLZ79 transgenic mice showed fl-gal staining only in very few cells while M24 (C and D) expressed in almost all cells. A 
similar pattern was seen in the ependyma (arrows) and striatum (st), where RLZ79 (E and F) expressed in very few and M24 (G and 
H) in many cells. Note that RNAse protection assays revealed higher RNA levels from RLZ79 than from M24 (Fig. 5). th, thalamus; 
mh, medial habenular nucleus; hc, hippoeampus; cp choroid plexus; s, septum. 
Discussion 
The complex 5'-UTR of the RARB2 mRNA is highly con- 
served between mice and humans, indicating an important 
function. Such a complex leader is not unique for the RARB2 
mRNA, but can be found in ,,o5  % of all vertebrate mRNAs, 
in particular those that encode for proteins with a proposed 
function in the regulation of cell growth and differentiation 
(Kozak,  1991). However, the role of these 5'-UTRs is un- 
known, although evidence suggests that they negatively in- 
terfere with translation (Marth et al., 1988; Rao et al., 1988; 
Arrick et al.,  1991; Darveau et al.,  1985).  It was therefore 
very surprising to see that the mutation of RAR~2-uORFs 
yielded no increase in the overall protein synthesis. 
Nevertheless, mutations in uORFs in the 5'-UTR of RARfl2- 
lacZ reporter gene constructs lead to differently regulated 
lacZ expression in hearts  and brains  of transgenic mice, 
while the expression in other tissues was very similar. In- 
terestingly, every mutation tested effected the level and time 
of expression during embryogenesis differently. M45, for ex- 
ample, already expressed at high levels in the hearts of day 
9.5 embryos, in contrast to M24 and M0. However, expres- 
sion in the brain was higher with M24 and M0 than with 
M45, at all developmental stages. These results show that 
uORFs in the RARB2-5'-UTR can modulate gene expression 
in a tissue specific and developmentally regulated manner. 
The best studied example of translational regulation by 
uORFs  is  the control  of C,  CN4  gene  expression  in  Sac- 
charomyces  cerevisiae  (Mueller  and  Hinnebusch,  1986; 
Miller and Hinnebusch, 1989; Abastado et al., 1991; Dever 
et  al.,  1992).  The  GCN4-open  wading  frame  (ORF)  is 
preceded by four small uORFs. Ribosomes initially translate 
the first uORF and subsequently reinitiate at a downstream 
AUG. Under conditions of  amino acid sufficiency, ribosomes 
reinitiate at AUG of uORF2-4, instead of the GCN4-AUG. 
The  frequency of reinitiation at  uORF2-4  is  reduced  in 
amino acid starved cells and thus, some ribosomes resume 
translation at the  GCN4-AUG  (Mueller and Hinnebusch, 
1986;  Abastado et al.,  1991). The reinitiation efficiency is 
regulated by the protein kinase GCN2, which is activated by 
uncharged tRNAs  and phosphorylates the eukaryotic ini- 
tiation factor 2  (eIF-2).  When phosphorylated, eIF-2  se- 
questers the guanine nucleotide exchange factor eIF-2B, and 
thus reduces the level of active ternary complexes (Dever et 
al., 1992).  Phosphorylation of eIF-2 by the heine regulated 
kinase (HRD or dsI has initially been described as a mecha- 
nism regulating the general protein synthesis in mammalian 
cells (Farrell et al.,  1977; Cooper and Farrell,  1977; De 
Benedetti and Baglioni, 1984; Chen et al.,  1991). Reinitia- 
tion is thought to be more sensitive to reduced levels of ter- 
nary complexes than cap-dependent initiation events,  be- 
cause it is less efficient (Kozak,  1989).  Thus, a molecular 
Zimmer et al.  Tissue  Specific Translational Regulation  1117 Figure  7. LacZ expression in adult hearts. Whole mount #-gal staining of adult hearts shows that RLZ79 (A) does not express/3-gal, in 
contrast to M24 (B). Note that RLZ79 and M24 mRNA levels were similar (Fig. 4). 
mechanism involved in the regulation of the general protein 
synthesis can be used to control gene specific translation as 
well. 
Surprisingly, very little is known about the role of uORFs 
in complex leaders of vertebrate genes. Experiments involv- 
ing expression constructs in which all or parts of the 5'-UTR 
were deleted showed that these leaders impaired translation 
(Marth et al., 1988; Ra et al., 1988; Arrick et al., 1991; Dar- 
veau et al.,  1985).  Therefore, it has been speculated that 
these 5'-UTRs might serve to reduce translation levels and 
that alterations in the translational efficiency of some proto- 
oncogenes may contribute to the development of  the neoplas- 
tic phenotype (Darveau et al., 1985; Marth et al., 1988; Rao 
et al., 1988). This idea was supported by the finding that over- 
expression of eIF-4F (or a 24-kD subunit elF-4E; Lazaris et 
al.,  1990;  Koromilas et al.,  1992)  or the IFN-inducible 
dsRNA-dependent protein kinase (dsRNA-PK; Koromilas et 
al.,  1992) results in malignant transformation, possibly by 
increasing  the  translation  of normally  poorly  translated 
mRNAs. 
Our results show that a translational mechanism involving 
uORFs can be a very effective means to control tissue- or 
cell-specific gene expression patterns. This suggests that the 
translational  control  involving complex  5'-UTRs  may be 
used to fine tune tissue specific gene expression patterns, 
rather than modulating the general level of protein synthesis. 
The molecular basis for tissue specific translational control 
of the RAR432 gene remains to be determined, but the dis- 
tinct expression patterns of the mutations indicate that sev- 
eral factors may be involved. It is conceivable that specific 
differences in the composition of initiation and/or elongation 
factors permit the translational machinery to traverse the 
uORFs in some cells, but not in others. A tissue specific ex- 
pression pattern has been reported for different  elF-4A genes 
(Nielsen and Trachsel,  1988) and elF-4E (Jaramillo et al., 
1991), but a comprehensive analysis for other factors is lack- 
ing. The activity of  the translational machinery is modulated 
by  posttranslational  modifications,  in  particular  through 
phosphorylation by several protein kinases (Ihazon et al., 
1989;  Hershey, 1991; Merrick,  1992;  Samuel,  1992).  It is 
conceivable  that  the  tissue  specific  and  developmentally 
coordinated activation or expression of these protein kinases 
may account for tissue specific differences in the ability of 
ribosomes to translate the RAR~2-ORF. 
The high degree of evolutionary conservation indicates 
that the RARB2 isoform has a unique and important func- 
tion. Furthermore, the very good conservation of the regula- 
tory 5'-UTR  suggests that the precise  control of RARB2 
translation in heart and brain is important. Interestingly, a 
relatively small number of cells in the brain expressed the 
wild-type construct at high levels, while most ceils were 
negative. As judged by the staining intensity,/~-gal levels in 
those cells were similar to that seen in the brain cells of mu- 
tant mice.  Thus it appears  that the regulation of RARB2 
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the brain is the enormous number of specific cell-cell  inter- 
actions, totaling as many as 10 ~5 (Kandel et al.,  1991). It is 
evident that this complexity  can be specified only through 
combinatorial  effects  of many  genes  in  conjunction  with 
epigenetic  processes.  Conceivably,  synaptic  inputs  might 
influence  the  translation  of regulatory  proteins  by modu- 
lating  the  translational  machinery  through  the  activity  of 
G-coupled receptors.  Such a mechanism could play an im- 
portant role in fine tuning the expression of many genes in 
neurons and in the specification of neuronal identity. 
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